Education
About Us
Working with TipRanks
Follow Us
David Schenkein Insider Profile
4 Followers
David Schenkein, Director at Agios Pharma, holds 72.72K shares in Denali Therapeutics (Ticker: DNLI), holds 448.00 shares in Regeneron (Ticker: REGN), holds 476.10K shares in Agios Pharma (Ticker: AGIO).
Profitable Transactions
7 out of 15 Profitable Transactions
Average Return
+0.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that David Schenkein holds in companies
Most Profitable Insider Trade
The most profitable trade made by David Schenkein
David Schenkein's Trading History
Agios Pharma
Jun 17, 2024
Director
Uninformative Buy
158.46K
$19.77M
Denali Therapeutics
Jun 05, 2025
Director
Uninformative Buy
―
$1.22M
Prime Medicine, Inc.
―
Director
―
―
Regeneron
Jan 06, 2025
Director
Uninformative Buy
―
$254.99K
Foundation Medicine
Jun 20, 2016
―
Uninformative Buy
240.65K
$2.98M
Bluebird Bio
Jun 22, 2020
―
Uninformative Buy
―
$33.96K
List of latest transactions for each holding click on a transaction to see David Schenkein's performance on stock
You May Also Like
David Schenkein insider profile FAQ
What is the percentage of profitable transactions made by David Schenkein?
The percentage of profitable transactions made by David Schenkein is 47%.
What is the average return per transaction made by David Schenkein?
The average return per transaction made by David Schenkein is 0.80%.
What stocks does David Schenkein hold?
David Schenkein holds: AGIO, DNLI, PRME, REGN, FMI, BLUE stocks.
What was David Schenkein’s latest transaction?
David Schenkein latest transaction was an Uninformative Buy of ―.
What was David Schenkein's most profitable transaction?
David Schenkein’s most profitable transaction was an Informative Buy of AGIO stock on March 27, 2014. The return on the trade was 164.20%.
What is David Schenkein's role in Agios Pharma?
David Schenkein's role in Agios Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.